PURPOSE:
To investigate enhancement with gadolinium benzyloxypropionictetraacetate (BOPTA) at magnetic resonance (MR) imaging to detect focal malignant hepatic lesions.
MATERIALS AND METHODS:
A phase II trial was performed in 34 patients.
Gd-BOPTA-enhanced spinecho (SE) and gradient-recalled-echo (GRE) Ti-weighted MR imaging were performed at 40 and 90 minutes after intravenous injection of 0.05 and 0.10 mmol/kg Gd-BOPTA.
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